Abstract
We updated the Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of ovarian cancer as version 5.1. The ovarian cancer guideline team of the KSGO published announced the fifth version (version 5.0) of its clinical practice guidelines for the management of ovarian cancer in December 2023. In version 5.0, the selection of the key questions and the systematic reviews were based on the data available up to December 2022. Therefore, we updated the guidelines version 5.0 with newly accumulated clinical data and added 5 new key questions reflecting the latest insights in the field of ovarian cancer between 2023 and 2024. For each question, recommendation was provided together with corresponding level of evidence and grade of recommendation, all established through expert consensus.
| Original language | English |
|---|---|
| Article number | e69 |
| Journal | Journal of Gynecologic Oncology |
| Volume | 36 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2025 |
Bibliographical note
Publisher Copyright:© 2025. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Hyperthermic Intraperitoneal Chemotherapy
- Mirvetuximab Soravtansine
- Ovarian Neoplasms
- Poly(ADP-ribose) Polymerase (PARP) Inhibitor
- Practice Guideline
- Risk-educing Salpingo-oophorectomy
- Trastuzumab Deruxtecan
Fingerprint
Dive into the research topics of 'Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver